Explore the Efficacy and Mechanism of Action of Tezepelumab in Eosinophilic Granulomatosis With Polyangiitis
Clinical trial NCT06230354 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT06230354
- Sponsor
- Imperial College London
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2024-05-15
- Primary completion
- 2026-09-01
- Enrollment
- 42
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.